BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 26221097)

  • 1. Synergistic effects of tacrolimus and azole antifungal compounds in fluconazole-susceptible and fluconazole-resistant Candida glabrata isolates.
    Denardi LB; Mario DA; Loreto ÉS; Santurio JM; Alves SH
    Braz J Microbiol; 2015 Mar; 46(1):125-9. PubMed ID: 26221097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of azole resistance in clinical isolates of Candida glabrata collected during a hospital survey of antifungal resistance.
    Sanguinetti M; Posteraro B; Fiori B; Ranno S; Torelli R; Fadda G
    Antimicrob Agents Chemother; 2005 Feb; 49(2):668-79. PubMed ID: 15673750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of Combined Antifungal Agents Against Multidrug-Resistant Candida glabrata Strains.
    Denardi LB; Keller JT; Oliveira V; Mario DAN; Santurio JM; Alves SH
    Mycopathologia; 2017 Oct; 182(9-10):819-828. PubMed ID: 28493006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Missense mutation in CgPDR1 regulator associated with azole-resistant Candida glabrata recovered from Thai oral candidiasis patients.
    Tantivitayakul P; Lapirattanakul J; Kaypetch R; Muadcheingka T
    J Glob Antimicrob Resist; 2019 Jun; 17():221-226. PubMed ID: 30658200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid acquisition of stable azole resistance by Candida glabrata isolates obtained before the clinical introduction of fluconazole.
    Borst A; Raimer MT; Warnock DW; Morrison CJ; Arthington-Skaggs BA
    Antimicrob Agents Chemother; 2005 Feb; 49(2):783-7. PubMed ID: 15673768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [In vitro activities of posaconazole, fluconazole, itraconazole, ketoconazole and voriconazole against Candida glabrata].
    Blanco MT; Cañadas J; García-Martos P; Marín P; García-Tapia A; Rodríguez J
    Rev Esp Quimioter; 2009 Sep; 22(3):139-43. PubMed ID: 19662547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of voriconazole and other antifungal agents against clinical isolates of Candida glabrata and Candida krusei.
    Drago M; Scaltrito MM; Morace G;
    Eur J Clin Microbiol Infect Dis; 2004 Aug; 23(8):619-24. PubMed ID: 15258831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistance reversal induced by a combination of fluconazole and tacrolimus (FK506) in Candida glabrata.
    Li H; Chen Z; Zhang C; Gao Y; Zhang X; Sun S
    J Med Microbiol; 2015 Jan; 64(Pt 1):44-52. PubMed ID: 25355935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Caspofungin activity against clinical isolates of azole cross-resistant Candida glabrata overexpressing efflux pump genes.
    Posteraro B; Sanguinetti M; Fiori B; La Sorda M; Spanu T; Sanglard D; Fadda G
    J Antimicrob Chemother; 2006 Aug; 58(2):458-61. PubMed ID: 16757500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of azole resistance among clinical isolates of Candida glabrata in Poland.
    Szweda P; Gucwa K; Romanowska E; Dzierz Anowska-Fangrat K; Naumiuk Ł; Brillowska-Da Browska A; Wojciechowska-Koszko I; Milewski S
    J Med Microbiol; 2015 Jun; 64(6):610-619. PubMed ID: 25818698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [In vitro activity of amphotericin B, fluconazole and itraconazole against Candida glabrata strains isolated from clinical samples].
    Hüseyin A; Sancak B; Arikan S
    Mikrobiyol Bul; 2007 Apr; 41(2):235-44. PubMed ID: 17682710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Inhibitory Effect of Human Beta-defensin-3 on
    Inthanachai T; Thammahong A; Edwards SW; Virakul S; Kiatsurayanon C; Chiewchengchol D
    Immunol Invest; 2021 Jan; 50(1):80-91. PubMed ID: 32316784
    [No Abstract]   [Full Text] [Related]  

  • 13. Correlation between broth microdilution and disk diffusion methods for antifungal susceptibility testing of caspofungin, voriconazole, amphotericin B, itraconazole and fluconazole against Candida glabrata.
    Kiraz N; Dag I; Oz Y; Yamac M; Kiremitci A; Kasifoglu N
    J Microbiol Methods; 2010 Aug; 82(2):136-40. PubMed ID: 20493911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antifungal activities of tacrolimus in combination with antifungal agents against fluconazole-susceptible and fluconazole-resistant Trichosporon asahii isolates.
    Kubiça TF; Denardi LB; Azevedo MI; Oliveira V; Severo LC; Santurio JM; Alves SH
    Braz J Infect Dis; 2016; 20(6):539-545. PubMed ID: 27697432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of antifungal agents alone and in combination against Candida glabrata strains susceptible or resistant to fluconazole.
    Alves IA; Bandeira LA; Mario DA; Denardi LB; Neves LV; Santurio JM; Alves SH
    Mycopathologia; 2012 Sep; 174(3):215-21. PubMed ID: 22528740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression Patterns of ABC Transporter Genes in Fluconazole-Resistant Candida glabrata.
    Gohar AA; Badali H; Shokohi T; Nabili M; Amirrajab N; Moazeni M
    Mycopathologia; 2017 Apr; 182(3-4):273-284. PubMed ID: 27744635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo activity of Sapindus saponaria against azole-susceptible and -resistant human vaginal Candida species.
    Damke E; Tsuzuki JK; Cortez DA; Ferreira IC; Bertoni TA; Batista MR; Donati L; Svidzinski TI; Consolaro ME
    BMC Complement Altern Med; 2011 May; 11():35. PubMed ID: 21542936
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Sun Y; Tan L; Yao Z; Gao L; Yang J; Zeng T
    Microbiol Spectr; 2022 Feb; 10(1):e0200721. PubMed ID: 35019705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Geographic variation in the frequency of isolation and fluconazole and voriconazole susceptibilities of Candida glabrata: an assessment from the ARTEMIS DISK Global Antifungal Surveillance Program.
    Pfaller MA; Diekema DJ; Gibbs DL; Newell VA; Barton R; Bijie H; Bille J; Chang SC; da Luz Martins M; Duse A; Dzierzanowska D; Ellis D; Finquelievich J; Gould I; Gur D; Hoosen A; Lee K; Mallatova N; Mallie M; Peng NG; Petrikos G; Santiago A; Trupl J; VanDen Abeele AM; Wadula J; Zaidi M;
    Diagn Microbiol Infect Dis; 2010 Jun; 67(2):162-71. PubMed ID: 20338711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of azole antifungal drug cross-resistance in Candida glabrata.
    Panackal AA; Gribskov JL; Staab JF; Kirby KA; Rinaldi M; Marr KA
    J Clin Microbiol; 2006 May; 44(5):1740-3. PubMed ID: 16672401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.